• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Per-Henrik Groop - Articles and news items

Boehringer Ingelheim logo
Novartis logo

Novartis drug Galvus® approved in EU

Industry news, News / 5 December 2011 / Novartis

The European Commission has approved Galvus® (vildagliptin) (50 mg once a day) for the treatment of type 2 diabetes patients with moderate or severe renal impairment…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +